# What is the purpose of using uroflowmetry in predicting TENS treatment outcomes for overactive bladder?

- Topic: FAQ
- Format: faq
- Source: Dr. Ubirajara Barroso Jr. by Securex

Uroflowmetry is analyzed as a predictor of the outcome of treatment with parasacral transcutaneous electrical nerve stimulation (TENS) in patients with pure overactive bladder.

**Read the full article:** [https://ubirajarabarroso.com.br/time-until-maximum-flow-rate-uroflowmetry-a-new-parameter-for-predicting-failure-of-transcutaneous-electrical-nerve-stimulation-tens-in-treating-children-and-adolescents-with-overactive-bladder/#faq-whatisthepurposeofusinguroflowmetryinpre](https://ubirajarabarroso.com.br/time-until-maximum-flow-rate-uroflowmetry-a-new-parameter-for-predicting-failure-of-transcutaneous-electrical-nerve-stimulation-tens-in-treating-children-and-adolescents-with-overactive-bladder/#faq-whatisthepurposeofusinguroflowmetryinpre)

## Structured Data

```json
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "author": {
    "@type": "Organization",
    "name": "Securex",
    "url": "https://securex.be",
    "department": {
      "@type": "Organization",
      "name": "Securex Expert Team"
    }
  },
  "inLanguage": "en",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is the purpose of using uroflowmetry in predicting TENS treatment outcomes for overactive bladder?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Uroflowmetry is analyzed as a predictor of the outcome of treatment with parasacral transcutaneous electrical nerve stimulation (TENS) in patients with pure overactive bladder."
      }
    }
  ],
  "url": "https://ubirajarabarroso.com.br/time-until-maximum-flow-rate-uroflowmetry-a-new-parameter-for-predicting-failure-of-transcutaneous-electrical-nerve-stimulation-tens-in-treating-children-and-adolescents-with-overactive-bladder/#faq-whatisthepurposeofusinguroflowmetryinpre"
}
```

---
*[Back to FAQ](faq.md?src=knowledge) · [All topics](knowledge.md?src=knowledge)*
*Source: Dr. Ubirajara Barroso Jr. via [Aztrix](https://aztrix.io?src=knowledge)*